Aurobindo Pharma launches ADQUEY ointment in the U.S.
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below:
- Aurobindo Pharma’s U.S. subsidiary Acrotech Biopharma Inc. has launched ADQUEY, a non‑steroidal topical PDE4 ointment, for atopic dermatitis.
- The launch marks the company’s entry into the U.S. dermatology market.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Aurobindo Pharma Enters US Dermatology Market With Launch Of ADQUEY Ointment For Atopic Dermatitis
Timeline
First reported by Free Press Journal on ; 1 article from 1 outlets so far.
Who is covering this story
- Center (1): Free Press Journal